Skip to content

Whole Body Vibration exercise in clinical, functional health and oxidative stress in women with fibromyalgia

Whole Body Vibration Stimulus training on clinical, functional and Redox Status in women with Fibromyalgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2x84bbn
Enrollment
Unknown
Registered
2022-04-28
Start date
2021-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

A total sample of forty women will be selected for the study, after recruitment the volunteers will be divided intra-groups, with twenty volunteers in each group, randomly distributed in Whole Body Vi

Sponsors

Universidade Federal dos Vales do Jequitinhonha e Mucuri
Lead Sponsor
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Collaborator

Eligibility

Sex/Gender
Female
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Women aged 35 to 70 years; with confirmed diagnosis of fibromyalgia between 1 and 3 years; presence of sensitivity in at least 11 of the 18 specific pain points according to the American College of Rheumatology criteria

Exclusion criteria

Exclusion criteria: Women who present; any concomitant illness that may be exacerbated by physical activity; pregnancy; orthopedic limitations; inflammatory diseases; degenerative; joints; respiratory or cardiovascular diseases; who are under follow-up with a psychiatrist; who perform physical activity for the same twice a week; present any of the possible contraindications for the intervention of Whole Body Vibration (acute hernia; thrombosis; diabetes, epilepsy; metabolic or neuromuscular diseases; orthopedic injuries and prostheses); use immunosuppressive medication

Design outcomes

Primary

MeasureTime frame
With the present study, it is expected that at the end of six weeks of Whole Body Vibration training in patients with fibromyalgia, they will show improvement in physical, functional performance and emotional aspects. In addition, a reduction in the profile of oxidative stress markers is expected in these subjects. Data will be analyzed using the SPSS statistical package, version twenty point zero (SPSS Inc., USA). Initially, a descriptive analysis of the variables will be carried out (mean and standard deviation or median and minimum-maximum values). The normality of the data will be verified by the Kolmogorov-Smirnov test and the comparison of all variables between the groups will be performed by the ANOVA test with Bonferroni's post hoc, for parametric variables and Kruskal-Wallis with Dunn's post hoc, for non-parametric variables. For all tests, p less than or equal to zero point zero five will be considered significant. To evaluate possible relationships between neuro-inflammatory variables and physical-functional and emotional aspects, correlation analysis will be performed using Pearson's coefficient (parametric variables) or Spearman's coefficient (non-parametric variables)

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactAna Cristina Lacerda

Universidade Federal dos Vales do Jequitinhonha e Mucuri

lacerdaacr@gmail.com+55-038-3532-1200

Outcome results

None listed

Source: REBEC (via WHO ICTRP)